N/A
Completed N=50
Virtual Reality in MVA for Miscarriage
Source: ClinicalTrials.gov NCT04466956 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Anxiety Rating — 4.4; 3.94 score on a scale
Summary
We are investigating the use of a virtual reality programme to reduce pain and anxiety experienced during manual vacuum aspiration.
Virtual reality (VR) is the computer-generated simulation of a three-dimensional environment that can be interacted with in a seemingly real way by a person using special electronic equipment. In this study a VR headset is worn by the patient allowing them to experience a relaxing environment whilst the procedure manual vacuum aspiration (MVA) is performed.
VR is mostly used in computer gaming but has uses in medical field and has been used in the treatment of long standing pain, treatment of burns, dentistry and treatment of cancer pain. However, its role in the management of pain and anxiety during gynaecological procedures like manual vacuum aspiration has not been researched. This study explores whether it has a place in the treatment of gynaecological pain and reduction of anxiety.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Anxiety Rating |
4.4; 3.94 | — |
| PRIMARY Pain Rating |
5.54; 4.68 | <0.01 sig |
Eligibility Criteria
Inclusion Criteria
Patients: Clinical indications for undergoing an MVA will be confirmed. Inclusion criteria will include all women of 18 - 50 years of age, planned for a MVA who are able and willing to give informed consent.
Exclusion Criteria
- Hearing impairments and blindness
- History of epilepsy or any previous seizures
- Any known anatomical characteristics that may make performing the office procedure more difficult (e.g., cervical conisation)
- Any known characteristics that make the patient unsuitable for undergoing MVA (e.g. known bleeding disorder, gestation >12 weeks)
- The denial or withdrawal of informed consent
Data sourced from ClinicalTrials.gov (NCT04466956). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.